Search in:

Cancer Management and Research Volume 11, 2019 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Complete response associated with immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis of nine randomized controlled trials

Jie LiDepartment of Respiratory Diseases, Second Clinical Medical College Shenzhen People’s Hospital, Jinan University, Shenzhen 518020, China, [email protected]Correspondence[email protected]

Qi HeDepartment of Respiratory Diseases, Second Clinical Medical College Shenzhen People’s Hospital, Jinan University, Shenzhen 518020, China, [email protected]

Xiu YuDepartment of Respiratory Diseases, Second Clinical Medical College Shenzhen People’s Hospital, Jinan University, Shenzhen 518020, China, [email protected]

Khalid KhanDepartment of Respiratory Diseases, Second Clinical Medical College Shenzhen People’s Hospital, Jinan University, Shenzhen 518020, China, [email protected]

Xuanwen WengDepartment of Respiratory Diseases, Second Clinical Medical College Shenzhen People’s Hospital, Jinan University, Shenzhen 518020, China, [email protected]

Minjie GuanDepartment of Respiratory Diseases, Second Clinical Medical College Shenzhen People’s Hospital, Jinan University, Shenzhen 518020, China, [email protected]

Pages 1623-1629 | Published online: 18 Feb 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (17)

Mike Mason, Óscar Lapuente-Santana, Anni S. Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D. Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I. Mäyränpää, Jie Bao, Emmy W. Verschuren, Eiman I. Ahmed, Michele Ceccarelli, Lance D. Miller, Gianni Monaco, Wouter R. L. Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D. Laajala, William J. Geese, Justin Guinney, Joseph D. Szustakowski, Benjamin G. Vincent & David P. Carbone. (2024) A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of Translational Medicine 22:1.
Crossref

Ogheneyoma Akpoviroro, Michelle Pramick & Abdul Adjei. (2023) Isolated Pancreatic Metastasis from a Lung Adenocarcinoma Primary: A Case Report and Literature Review. Case Reports in Oncology, pages 988-998.
Crossref

Matteo Santoni, Alessandro Rizzo, Jakub Kucharz, Veronica Mollica, Matteo Rosellini, Andrea Marchetti, Elisa Tassinari, Fernando Sabino Marques Monteiro, Andrey Soares, Javier Molina-Cerrillo, Enrique Grande, Nicola Battelli & Francesco Massari. (2023) Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis. Cancer Immunology, Immunotherapy 72:6, pages 1365-1379.
Crossref

Akiko Koizumi, Yukiho Tamura, Ryohei Yoshida, Chie Mori, Yusuke Ono, Mishie Tanino, Yusuke Mizukami & Takaaki Sasaki. (2023) Two Cases of SMARCA4-Deficient Non-small Cell Lung Cancer (NSCLC) with Improved Performance Status (PS) after Treatment with Immune Checkpoint Inhibitors (ICIs). Cureus.
Crossref

Rocio Tamayo-Bermejo, Juan Carlos del Rio-Valencia, Beatriz Mora-Rodriguez & Isabel Muñoz-Castillo. (2021) Effectiveness and safety of pembrolizumab monotherapy in patients with locally advanced or metastatic non-small-cell lung cancer. Journal of Oncology Pharmacy Practice 29:1, pages 138-144.
Crossref

Amanda Lusa, Carolina Alvarez, Shruti Saxena Beem, Todd A. Schwartz & Rumey Ishizawar. (2022) Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy. BMC Rheumatology 6:1.
Crossref

Patricia Iranzo, Ana Callejo, Juan David Assaf, Gaspar Molina, Daniel Esteban Lopez, David Garcia-Illescas, Nuria Pardo, Alejandro Navarro, Alex Martinez-Marti, Susana Cedres, Caterina Carbonell, Joan Frigola, Ramon Amat & Enriqueta Felip. (2022) Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer. Frontiers in Medicine 9.
Crossref

Marta Vilaça, Catarina Silva, Fernanda Estevinho & Helena Magalhães. (2022) Immunotherapy in stage IV non-small cell lung cancer in a patient with Grave’s disease: safety and biomarkers of response. BMJ Case Reports 15:1, pages e245632.
Crossref

Peter Murphy, David Glynn, Sofia Dias, Robert Hodgson, Lindsay Claxton, Lucy Beresford, Katy Cooper, Paul Tappenden, Kate Ennis, Alessandro Grosso, Kath Wright, Anna Cantrell, Matt Stevenson & Stephen Palmer. (2021) Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health Technology Assessment 25:76, pages 1-228.
Crossref

Peey-Sei Kok, Won-Hee Yoon, Sally Lord, Ian Marschner, Michael Friedlander & Chee Khoon Lee. (2021) Tumor Response End Points as Surrogates for Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-Analysis. JCO Precision Oncology:5, pages 1151-1159.
Crossref

Eiji Takeuchi, Yuri Okamoto, Naoki Takahashi, Shun Morizumi, Yuko Toyoda, Naoto Kuroda & Kenji Yorita. (2020) Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report. Thoracic Cancer 12:2, pages 259-263.
Crossref

Katy Cooper, Paul Tappenden, Anna Cantrell & Kate Ennis. (2020) A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer. British Journal of Cancer 123:11, pages 1686-1696.
Crossref

Ken‐ichi Tomiyama, Norimasa Ito, Kenichi Hayashi, Yuki Kawamoto, Hiroaki Shinoda & Nobuyuki Katakami. (2020) Oesophagobronchial perforations after placement of an oesophageal self‐expanding metallic stent. Respirology Case Reports 8:4.
Crossref

Federica Riccardo, Giuseppina Barutello, Angela Petito, Lidia Tarone, Laura Conti, Maddalena Arigoni, Chiara Musiu, Stefania Izzo, Marco Volante, Dario Livio Longo, Irene Fiore Merighi, Mauro Papotti, Federica Cavallo & Elena Quaglino. (2020) Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas. Vaccines 8:2, pages 166.
Crossref

Thierry Berghmans, Valérie Durieux, Lizza E. L. Hendriks & Anne-Marie Dingemans. (2020) Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept. Frontiers in Medicine 7.
Crossref

Babak Baseri, Bachar Samra, Eric Tam, Edwin Chiu & Andrea Leaf. (2019) An Exceptional Responder to Nivolumab in Metastatic Non-Small-Cell Lung Cancer: A Case Report and Literature Review of Long-Term Survivors. Case Reports in Oncological Medicine 2019, pages 1-7.
Crossref

Theodoulakis Christofi, Stavroula Baritaki, Luca Falzone, Massimo Libra & Apostolos Zaravinos. (2019) Current Perspectives in Cancer Immunotherapy. Cancers 11:10, pages 1472.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Complete response associated with immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis of nine randomized controlled trials

Articles from other publishers (17)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Complete response associated with immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis of nine randomized controlled trials

Citations (17)

Articles from other publishers (17)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date